Rs 2,701 Crore Order Book: Multibagger Oil & Gas Field Services Provider Secures Strategic Asset Control Rs 2,701 Crore Order Book: Multibagger Oil & Gas Field Services Provider Secures Strategic Asset Control The stock has delivered a 1-year return of 55 per cent and a 3-year return of 320 per cent. DSIJ Intelligence / Friday, April 4, 2025 0 227 Article rating: 3.7 The stock has delivered a 1-year return of 55 per cent and a 3-year return of 320 per cent. Read more
Rs 6,320 Crore Order Book: Multibagger Railway Wagons Company Secures Land for India’s First Forged Railwheel & Axle Manufacturing Plant in Odisha Rs 6,320 Crore Order Book: Multibagger Railway Wagons Company Secures Land for India’s First Forged Railwheel & Axle Manufacturing Plant in Odisha The stock gave multibagger returns of 290 per cent in 2 years and a whopping 4,500 per cent in 5 years. DSIJ Intelligence / Friday, April 4, 2025 0 673 Article rating: 3.4 The stock gave multibagger returns of 290 per cent in 2 years and a whopping 4,500 per cent in 5 years. Read more
Espire Hospitality Limited Expands With "Zana By The Ganges, Rishikesh," Enhancing Its Luxury Offerings Espire Hospitality Limited Expands With "Zana By The Ganges, Rishikesh," Enhancing Its Luxury Offerings With a PE ratio of 126, the company trades at a premium compared to the industry PE of 34.4. The company has ROCE of 10.4 per cent and ROE of 126.11 per cent. DSIJ Intelligence / Friday, April 4, 2025 0 95 Article rating: 5.0 Read more
Ashish Kacholia Portfolio Stock: Partners with Thomas Cook India to Transform Corporate Travel with an Advanced Expense Management Platform Ashish Kacholia Portfolio Stock: Partners with Thomas Cook India to Transform Corporate Travel with an Advanced Expense Management Platform The company has achieved a one-year return of 25.26 per cent DSIJ Intelligence / Friday, April 4, 2025 0 207 Article rating: 5.0 The company has achieved a one-year return of 25.26 per cent Read more
Large-Cap Injectable-Focused Pharma Company Gains USFDA Nod for Key Pain Management Drug Large-Cap Injectable-Focused Pharma Company Gains USFDA Nod for Key Pain Management Drug With a PE ratio of 36.6, the company trades at a premium compared to the industry PE of 36.4. The company has ROCE of 13.6 per cent and ROE of 9.26 per cent. DSIJ Intelligence / Friday, April 4, 2025 0 226 Article rating: 5.0 With a PE ratio of 36.6, the company trades at a premium compared to the industry PE of 36.4. The company has ROCE of 13.6 per cent and ROE of 9.26 per cent. Read more